{"url":"https://lda.senate.gov/api/v1/filings/9f532be0-e55a-435c-8b86-c510a5866431/","filing_uuid":"9f532be0-e55a-435c-8b86-c510a5866431","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/9f532be0-e55a-435c-8b86-c510a5866431/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Mike McKay, Principal","dt_posted":"2026-07-20T14:49:24-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1717 K Street, NW","registrant_address_2":"9th Floor","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":400703105,"url":"https://lda.senate.gov/api/v1/registrants/400703105/","house_registrant_id":null,"name":"EMPIRE CONSULTING GROUP","description":"Government Relations","address_1":"1050 17th Street NW","address_2":"Suite 550","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20036","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MIKE MCKAY","contact_telephone":"+1 202-787-5740","dt_updated":"2026-07-27T21:03:40.855794-04:00"},"client":{"id":194386,"url":"https://lda.senate.gov/api/v1/clients/194386/","client_id":36,"name":"PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA","general_description":"Pharmaceuticals","client_government_entity":false,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2011-01-27"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"HR 9504-The Tax-Exempt Hospital Transparency Act. 340B Program Violations. PBM reform. Issues related to Most Favored Nations. Issues related to health access.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":149092,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"HAYES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":53388,"prefix":null,"prefix_display":null,"first_name":"MIKE","nickname":null,"middle_name":null,"last_name":"MCKAY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107217,"prefix":null,"prefix_display":null,"first_name":"E.","nickname":null,"middle_name":"BRANDON","last_name":"GARRETT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}